𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disposition of valproic acid in patients with liver disease

✍ Scribed by U. Klotz; T. Rapp; W. A. Müller

Publisher
Springer
Year
1978
Tongue
English
Weight
670 KB
Volume
13
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of valproic acid in man
Disposition of valproic acid in man
✍ R. Gugler; A. Schell; M. Eichelbaum; W. Fröscher; H. -U. Schulz 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 749 KB
Disposition of antipyrine in patients wi
Disposition of antipyrine in patients with extensive metastatic liver disease
✍ G.-M. Robertz-Vaupel; K. D. Lindecken; T. Edeki; C. Funke; S. Belwon; H. J. Deng 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 536 KB

In the present study the effect of metastatic liver disease on hepatic drug metabolism has been examined by studying the pharmacokinetics of antipyrine and the urinary excretion of antipyrine and its three major metabolites (4-hydroxyantipyrine, norantipyrine, and 3-hydroxymethylantipyrine) in 12 pa

Disposition and Metabolism of Metronidaz
Disposition and Metabolism of Metronidazole in Patients with Liver Failure
✍ Geoffrey Farrell; Judith Baird-Lambert; Mara Cvejic; Neil Buchanan 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

A pharmacokinetic study of metronidazole disposition was performed in 10 patients with severe liver disease, the majority of whom also had impaired renal function. Following a single intravenous dose, systemic clearance of metronidazole was decreased by 66% in patients compared with healthy

Plasma levels of pipecolic acid in patie
Plasma levels of pipecolic acid in patients with chronic liver disease
✍ Hironaka Kawasaki; Tatsuaki Hori; Masako Nakajima; Kenzo Takeshita 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Plasma levels of pipecolic acid, which is a minor metabolite of lysine, were determined by high-performance liquid chromatography in 22 patients with chronic liver disease, composed of 6 patients with chronic active hepatitis, 11 with liver cirrhosis and 5 with hepatocellular carcinoma. The plasma l